Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control

RATIONALE: Treatment of the most widely abused drugs, nicotine and alcohol, is hampered by high rates of relapse. Varenicline tartrate, an α4β2 nicotinic receptor partial agonist, is currently prescribed as a smoking cessation aid. However, there is emerging evidence that it may also modulate alcoho...

Descripción completa

Detalles Bibliográficos
Autores principales: Wouda, Jelte A., Riga, Danai, De Vries, Wendy, Stegeman, Mathijs, van Mourik, Yvar, Schetters, Dustin, Schoffelmeer, Anton N. M., Pattij, Tommy, De Vries, Taco J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121941/
https://www.ncbi.nlm.nih.gov/pubmed/21331520
http://dx.doi.org/10.1007/s00213-011-2213-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121941/
https://www.ncbi.nlm.nih.gov/pubmed/21331520
http://dx.doi.org/10.1007/s00213-011-2213-8

Ejemplares similares